BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37692575)

  • 1. MicroRNA Profiling in Circulating Exosomes in Oral Squamous Cell Carcinoma: A Systematic Review.
    Y D; Ramani P; Yuwanati M; Ramalingam K; S G
    Cureus; 2023 Aug; 15(8):e43235. PubMed ID: 37692575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between dental implants and oral squamous cell carcinoma.
    Afrashtehfar KI; Almomani MM; Momani M
    Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
    Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
    Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
    Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC.
    Luo Y; Liu F; Guo J; Gui R
    Sci Rep; 2020 Aug; 10(1):13739. PubMed ID: 32792549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y; Shuai Y; Wang H; Li H; Li Y
    Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
    Elmahgoub F
    Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation.
    He S; Zhang W; Li X; Wang J; Chen X; Chen Y; Lai R
    Bioengineered; 2021 Dec; 12(1):2164-2174. PubMed ID: 34098850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
    Wang WZ; Cao X; Bian L; Gao Y; Yu M; Li YT; Xu JG; Wang YH; Yang HF; You DY; He YW
    BMC Cancer; 2023 Jun; 23(1):591. PubMed ID: 37365497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
    Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
    Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we detect biomarkers of oral squamous cell carcinoma from saliva or mouth swabs?
    Gaw G; Gribben M
    Evid Based Dent; 2022 Mar; 23(1):32-33. PubMed ID: 35338327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Broder's and Bryne's Grading System for Oral Squamous Cell Carcinoma With Lymph Node Metastases and Prognosis: A Scoping Review.
    Thamilselvan S; Pandiar D; Krishnan RP; Ramalingam K; Pavithran P
    Cureus; 2024 Jan; 16(1):e51713. PubMed ID: 38313967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA Associated With Glucose Transporters in Oral Squamous Cell Carcinoma: A Systematic Review.
    R P; Yuwanati M; Sekaran S; M S
    Cureus; 2023 Sep; 15(9):e46057. PubMed ID: 37900425
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Deng W; Meng Y; Wang B; Wang CX; Hou CX; Zhu QH; Tang YT; Ye JH
    Cell Cycle; 2022 Aug; 21(16):1775-1783. PubMed ID: 35485349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
    Li L; Li C; Wang S; Wang Z; Jiang J; Wang W; Li X; Chen J; Liu K; Li C; Zhu G
    Cancer Res; 2016 Apr; 76(7):1770-80. PubMed ID: 26992424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
    Coon J; Kingsley K; Howard KM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
    Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.